Skip to content

Home / The project

The project

A translational study of adverse childhood experiences and depression in adolescence.

Introduction

Rates of youth depression and suicide are rising worldwide and present a critical public health problem. This is of particular concern in girls, as the prevalence and severity of depression are higher than in boys. Despite these apparent sex differences, only a few studies have analyzed the influence of sex in the development of depression, and even fewer focused on adolescence. Several risk factors have been associated with an increased risk of developing depression in adolescents. Still, exposure to adverse childhood experiences (ACEs) stands out, such as interpersonal trauma (child maltreatment, physical and sexual assault, the witnessing of violence, and school bullying). Although prior research has established the relationship between trauma and mental health outcomes, very few studies have specifically examined the impact of childhood trauma on adolescent clinical samples with depression and suicidality.

This project is intended to understand better the characteristics of and precursors for adolescent depression and suicidality, combining studies in patients (impact of bullying in adolescents admitted for depression) and experimental mice (depressive-related behaviors induced by early life, psychosocial, and chronic stress). Moreover, we analyze the influence of ACEs on the likelihood of substance abuse among adolescents admitted for depression, in parallel with the analysis of the impact of early life, psychosocial, and chronic stress on the vulnerability to alcohol consumption in mice. With the final goal of establishing gender-based differences, all the research is conducted on both sexes.

Moreover, this project aims to elucidate more precisely the neurobiological alterations underlying the development of depressive disorders and vulnerability to alcohol by analyzing changes in neuroplasticity and neuroinflammatory markers in mice and plasma and lymphocytes in adolescent patients. The underlying mechanisms may vary depending on the cause (type of stress) and may help to discover specific markers for prevention and the design of new pharmacological therapies. In fact, the final part of the project focuses on determining new potential therapeutic options for the treatment of depression among adolescents, evaluating the potential of CBD and a PPARβδ receptor agonist to prevent behavioral and brain plasticity alterations induced by each type of stress in mice in a sex-specific way.

Objectives

General objective 1

To study the behavioral and neurobiological impact of early life, psychosocial, and chronic stress in adolescence from a translational point of view (mice and humans) and a gender perspective.

  1. 1.1

    To ascertain the impact of traumatic experiences, with a particular focus on bullying, on the prognosis of depression and suicidal ideation in adolescents admitted for depression, and to study differences in depressive-related behaviors induced by early life, psychosocial and chronic stress in a sex-specific way in mice.

  2. 1.2

    To evaluate differences in neuroinflammation and neuroplasticity alterations in the medial prefrontal cortex (mPFC) and hippocampus (HIP) induced by early life, psychosocial and chronic stress in a sex-specific way in mice.

  3. 1.3

    To ascertain the influence of adverse childhood experiences (ACEs), particularly bullying, on the likelihood of substance abuse among adolescents admitted for depression, and to evaluate differences in the impact of early life, psychosocial and chronic stress on the vulnerability to alcohol consumption in a sex-specific way in mice.

  4. 1.4

    To identify differences in biomarker alterations, both psychological and biological at the peripheral level (lymphocytes), in a sex-specific way in adolescents with depression and alcohol abuse.

General objective 2

To study the therapeutic potential of cannabidiol (CBD) and a PPARβδ receptor agonist in modulating behavioral and brain plasticity alterations induced by early life, psychosocial and chronic stress in a sex-specific way.

  1. 2.1

    To study the antidepressant dose-response effects of CBD and the PPARβδ agonist in modulating early stress-induced depressive-related behaviors and the associated molecular alterations in the mPFC and HIP in mice.

  2. 2.2

    To study the antidepressant dose-response effects of CBD and the PPARβδ agonist in modulating psychosocial stress-induced depressive-related behaviors and the associated molecular alterations in the mPFC and HIP in mice.

  3. 2.3

    To study the antidepressant dose-response effects of CBD and the PPARβδ agonist in modulating chronic stress-induced depressive-related behaviors and the associated molecular alterations in the mPFC and HIP in mice.

Research lines

01Clinical study

Adolescents admitted for depression: impact of adverse childhood experiences (bullying) on the prognosis of depression and the likelihood of substance abuse

Led by Gabriel Rubio Valladolid

Objectives
  1. To evaluate the impact of adverse childhood experiences, with a particular focus on bullying, on: 1) the prognosis of depression and suicidal ideation, 2) the likelihood of substance abuse, and 3) gene expression patterns.
  2. To identify psychological and biological markers in adolescents with depression and alcohol abuse.
Subjects

Patients admitted for depression in the Short Admission Unit for Adolescents of the Hospital Universitario 12 de Octubre (HU12O), with and without adverse childhood experiences.

Control subjects without a history of psychiatric diseases.

Psychological measurements

Interviews are conducted with both the adolescent and one parent. Scales and questionnaires are used to determine traumatic experiences, diagnosis and severity of depression, and drug abuse comorbidity.

Biological measurements

Blood samples are obtained to isolate lymphocytes and carry out transcriptomics. Real-time PCR studies of selected genes (based on the transcriptomic results) are performed with the objective of obtaining crucial information about specific stress-driven differences in gene expression patterns.

Patient selection, genetic studies and rating scales.
Patient selection, genetic studies and rating scales.
See the techniques of this line
02Animal model

Behavioral and neurobiological consequences of early life stress in mice. Effects of CBD and GW0742

Led by María Salud García Gutiérrez

Objectives
  1. To evaluate the impact of maternal separation (MS) on: 1) the development of depressive behaviors and 2) the vulnerability to alcohol consumption.
  2. To evaluate sex differences in the neurobiological consequences of MS (neuroinflammation and alterations of neuroplasticity in the mPFC and HIP).
  3. To evaluate the potential of CBD and GW0742 to reverse the behavioral and neurobiological consequences of MS.
Subjects

Male and female C57BL/6J mice without stress exposure (controls) or exposed to 12 hours of MS on postnatal days (PND) 8 and 12.

Pharmacological treatments

Administration of physiological saline, CBD, GW0742 and CBD+GW0742 to control and MS mice.

Behavioral measurements

In adolescence (PND 28), the behavior of the mice is tested in different animal models of emotional reactivity (anxiety-like behavior, social interaction, behavioral despair, anhedonia), cognitive impairments and vulnerability to ethanol consumption (oral ethanol self-administration and drinking in the dark).

Biological measurements

About 4–6 weeks after stress, spatial transcriptomics, real-time PCR and immunohistochemistry analyses are performed in brain samples of mPFC and HIP to study the molecular alterations induced by MS.

Maternal separation and behavioral assessment.
Maternal separation and behavioral assessment.
See the techniques of this line
03Animal model

Behavioral and neurobiological consequences of psychosocial stress in mice. Effects of CBD and GW0742

Led by María Asunción Aguilar Calpe

Objectives
  1. To evaluate the impact of repeated social defeat (RSD) on: 1) the development of depressive behaviors and 2) the vulnerability to alcohol consumption.
  2. To evaluate sex differences in the neurobiological consequences of RSD (neuroinflammation and alterations of neuroplasticity in the mPFC and HIP).
  3. To evaluate the potential of CBD and GW0742 to reverse the behavioral and neurobiological consequences of RSD.
Subjects

Male and female C57BL/6J mice without stress exposure (controls) or exposed to 10 days (PND 28–38) of social defeat (males) or vicarious social defeat (females).

Pharmacological treatments

Administration of physiological saline, CBD, GW0742 and CBD+GW0742 to control and RSD mice.

Behavioral measurements

In adolescence (PND 38), the behavior of the mice is tested in different animal models of emotional reactivity (anxiety-like behavior, social interaction, behavioral despair, anhedonia), cognitive impairments and vulnerability to ethanol consumption (oral ethanol self-administration and drinking in the dark).

Biological measurements

About 4–6 weeks after stress, spatial transcriptomics, real-time PCR and immunohistochemistry analyses are performed in brain samples of mPFC and HIP to study the molecular alterations induced by RSD.

Repeated social defeat (10 days) and behavioral assessment.
Repeated social defeat (10 days) and behavioral assessment.
See the techniques of this line
04Animal model

Behavioral and neurobiological consequences of unpredictable chronic mild stress in mice. Effects of CBD and GW0742

Led by María Salud García Gutiérrez · María Asunción Aguilar Calpe

Objectives
  1. To evaluate the impact of unpredictable chronic mild stress (UCMS) on: 1) the development of depressive behaviors and 2) the vulnerability to alcohol consumption.
  2. To evaluate sex differences in the neurobiological consequences of UCMS (neuroinflammation and alterations of neuroplasticity in the mPFC and HIP).
  3. To evaluate the potential of CBD and GW0742 to reverse the behavioral and neurobiological consequences of UCMS.
Subjects

Male and female C57BL/6J mice without stress exposure (controls) or exposed to 3 weeks (PND 28–48) of UCMS.

Pharmacological treatments

Administration of physiological saline, CBD, GW0742 and CBD+GW0742 to control and UCMS mice.

Behavioral measurements

In adolescence (PND 49), the behavior of the mice is tested in different animal models of emotional reactivity (anxiety-like behavior, social interaction, behavioral despair, anhedonia), cognitive impairments and vulnerability to ethanol consumption (oral ethanol self-administration and drinking in the dark).

Biological measurements

About 4–6 weeks after stress, spatial transcriptomics, real-time PCR and immunohistochemistry analyses are performed in brain samples of mPFC and HIP to study the molecular alterations induced by UCMS.

Unpredictable chronic mild stress (21 days) and behavioral assessment.
Unpredictable chronic mild stress (21 days) and behavioral assessment.
See the techniques of this line